Description

7-tert-Butyl 1-Ethyl 5,6-Dihydroimidazo[1,5-A]Pyrazine-1,7(8H)-Dicarboxylate is a high-purity, advanced pharmaceutical intermediate belonging to the imidazopyrazine class of heterocyclic compounds. This compound is of significant value for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. It is primarily needed by research institutions, contract development and manufacturing organizations (CDMOs), and pharmaceutical companies engaged in the development of new drug candidates.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of new drug molecules, especially for central nervous system (CNS) and oncology targets.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop compounds with improved efficacy and pharmacokinetic profiles.
• Process Chemistry Development: Serves as a starting material or intermediate in scaling up synthetic routes from laboratory to pilot plant and commercial production.
• Bioconjugation & Probe Synthesis: Potential utility in creating chemical probes or tagged molecules for biochemical and diagnostic research applications.
• Academic & Institutional Research: Employed in universities and research institutes for exploring new heterocyclic chemistry and novel synthetic methodologies.

Basic Information

Product Name	7-tert-Butyl 1-Ethyl 5,6-Dihydroimidazo[1,5-A]Pyrazine-1,7(8H)-Dicarboxylate
CAS No.	1416447-72-7
Molecular Formula	C15H23N3O4
Molecular Weight	309.36 g/mol
Synonyms	1-Ethyl 7-tert-butyl 5,6-dihydroimidazo[1,5-a]pyrazine-1,7(8H)-dicarboxylate; tert-Butyl 1-ethyl-5,6-dihydroimidazo[1,5-a]pyrazine-1,7(8H)-dicarboxylate; 1,7(8H)-Dicarboxylic acid, 5,6-dihydroimidazo[1,5-a]pyrazine-, 1-ethyl 7-(1,1-dimethylethyl) ester; Imidazo[1,5-a]pyrazine-1,7(8H)-dicarboxylic acid, 5,6-dihydro-, 1-ethyl 7-(1,1-dimethylethyl) ester; CAS 1416447-72-7
EINECS	Contact for details

Quality Control

Our 7-tert-Butyl 1-Ethyl 5,6-Dihydroimidazo[1,5-A]Pyrazine-1,7(8H)-Dicarboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic data (HPLC/GC) are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.